LDE.F Landec Corporation

Healthcare Pharmaceuticals Frankfurt Exchange
5.65 EUR
Close of Nov 12, 2026
3.12 7.30
Market cap
EUR 214M
P/E
-
P/B
203.86x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Aug 2026.

Is LDE.F undervalued?

Graham number

The Graham number of Landec Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Landec Corporation fundamental analysis

No fundamental analysis for Landec Corporation yet.

Landec Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Landec Corporation

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company a…

Full company profile